Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 606-611

  Xia, Hong ^a   Bleicher, Richard J ^a   Gupta, Vicram ^a   Zaren, Howard A ^a   Singh, Shivendra V ^a  

^a MERCY HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; MITOMYCIN C;

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; MITOMYCIN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; URINARY BLADDER NEOPLASMS;

EID: 0030944854     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970304)70:5<606::AID-IJC19>3.0.CO;2-A     Document Type: Article

References (18)

1. BECK, W.T., The cell biolocy of multiple druc resistance. Biochcm. Phannacol., 36, 2879-2887 (1987).
2. BRADFORD, M.M., A rapid and sensitive method for the quantitation of microeram quantities of protein utilizina the principle of protein-dye binding. Anal. Biochem., 12, 248-254 (1976).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid suanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
4. CROOKE, S.T. and BRADNER, W.T., Mitomycin C: a review. Cancer Treat. Rev., 3, 121-139 (1976).
5. DAVIES, S.M., ROBSON, C.N., DAVIES, S.L. and HICKSON, I.D., Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J. biol. Chem., 263, 17724-17729 (1988).
6. DORR, R.T., LIDDIL, J.D., TRENT, J.M. and DALTON, W.S., Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance. Biochem. Pharmacol., 36, 3115-3120 (1987).
7. FRIEDMAN, H.S., DOLAN, M.E., KAUFMANN, S.H., COLVIN, O.M., GRIFFITH, O.W., MOSCHEL, R.C., SCHULD, S.C., BIGNER, D.D. and ALI-OSMAN, F., Elevated DNA polymerase α, DNA polymerase β, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is crossresistant to nitrosoureas and topotecan. Cancer Res., 54, 3487-3493 (1994).
8. FRY, A.M., CHRESTA, C.M., DAVIES, S.M., WALKER, M.C., HARRIS, A.L., HARTLEY, J.A., MASTERS, J.R.W. and HICKSON, I.D., Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res., 51, 6592-6595 (1991).
9. HOBAN, P.R., WALTON, M.I., ROBSON, C.N., GODDEN, J., STRATFORD, I.J., WORKMAN, P., HARRIS, A.L. and HICKSON, I.D., Decreased NADPH: cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res., 50, 4692-4697 (1990).
10. KOBAYASHI, E., OKABE, M., KONO, M., ARAL H., KASAI, M., GOMI, K., LEE, J.-H., INABA, M. and TSURUO, T., Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C. Cancer Chemother. Pharmacol, 32, 20-24 (1993).
11. LING, V., Genetic basis of drug resistance in mammalian cells. In: N. Bruchovsky and J.H. Goldie (eds.), Drugs and hormone resistance in neoplasis, pp. 1-20, CRC Press, Boca Raton (1982).
12. LIU, L.F., DNA topoisomerase poisons as antitumor drues. Ann. Rev. Biochem., 58, 351-375 (1989).
13. NELSON, W.G., Liu, L.F. and COFFEY, D.S., Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenoearcinoma cells. Nature (Land.), 322, 187-189 (1986).
14. POMMIER, Y., KERRIGAN, D., SCHWARTZ, R.E., SWACK, J.A. and MCCURDY, A., Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46, 3075-3081 (1986).
15. + monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase H-tarseted drues. Cancer Res., 52, 2782-2790 (1992).
16. Ross, D., SIEGEL, D., BEAU., H., PRAKASH, A.S., MULCAHY, R.T. and GIBSON, N.W., DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev., 12, 83-101 (1993).
17. SINON, S.V., SCALAMOGNA, D., XIA, H., O'TOOLE, S., ROY, D., EMERSON, E.O., GUPTA, V. and ZAREN, H.A., Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line. Int. J. Cancer, 65, 852-857 (1996).
18. SPIRIDONIDIS, C.A., CHATTERJEE, S., PETZOLD, S.J. and BERGER, N.A., Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines. Cancer Res., 49, 644-650 (1989).